Apremilast Coadministered with Secukinumab for Safe and Effective Control of Psoriasis with Resultant Reduction of Maintenance Dose of the Biologic

Psoriasis is a chronic immune-mediated inflammatory condition, affecting 2–3% of the population. In recent years, advent of biologics, including secukinumab, have been a major advancement in the management of difficult-to-treat plaque psoriasis. However, high cost of biologics is often a deterrent,...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Indian J Dermatol
Main Authors: De, Abhishek, Das, Sudip, Dhoot, Dhiraj, Sarda, Aarti
Format: Artigo
Sprog:Inglês
Udgivet: Wolters Kluwer - Medknow 2019
Fag:
Case Report
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6537682/
https://ncbi.nlm.nih.gov/pubmed/31148865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijd.IJD_548_18
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker